PDL BioPharma (PDLI)

PDL Biopharma Inc (PDLI) Q2 2020 Earnings Call Transcript
Aug. 7, 2020 | Price: Free! | Source: Motley Fool

PDL BioPharma, Inc. (PDLI) CEO Dominique Monnet on Q2 2020 Results - Earnings Call Transcript
Aug. 7, 2020 | Price: Free! | Source: Seeking Alpha

PDL Biopharma Inc (PDLI) Q1 2020 Earnings Call Transcript
May 8, 2020 | Price: Free! | Source: Motley Fool

PDL BioPharma's (PDLI) CEO Dominique Monnet on Q1 2020 Results - Earnings Call Transcript
May 8, 2020 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. (PDLI) CEO Dominique Monnet on Q4 2019 Results - Earnings Call Transcript
March 12, 2020 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO Dominique Monnet on Q3 2019 Results - Earnings Call Transcript
Nov. 7, 2019 | Price: Free! | Source: Seeking Alpha

PDL Biopharma Inc (PDLI) Q3 2019 Earnings Call Transcript
Nov. 7, 2019 | Price: Free! | Source: Motley Fool

PDL Biopharma Inc (PDLI) Q2 2019 Earnings Call Transcript
Aug. 8, 2019 | Price: Free! | Source: Motley Fool

PDL BioPharma's (PDLI) CEO Dominique Monnet on Q2 2019 Results - Earnings Call Transcript
Aug. 7, 2019 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. (PDLI) CEO Dominique Monnet on Q1 2019 Results - Earnings Call Transcript
May 9, 2019 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Inc.'s (PDLI) CEO Dominique Monnet on Q4 2018 Results - Earnings Call Transcript
March 14, 2019 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Inc. (PDLI) CEO John McLaughlin on Q3 2018 Results - Earnings Call Transcript
Nov. 6, 2018 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Inc. (PDLI) CEO John McLaughlin on Q2 2018 Results - Earnings Call Transcript
Aug. 8, 2018 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q4 2017 Results - Earnings Call Transcript
March 8, 2018 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q3 2017 Results - Earnings Call Transcript
Nov. 2, 2017 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q2 2017 Results - Earnings Call Transcript
Aug. 4, 2017 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q1 2017 Results - Earnings Call Transcript
May 3, 2017 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q4 2016 Results - Earnings Call Transcript
March 1, 2017 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q3 2016 Results - Earnings Call Transcript
Nov. 3, 2016 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q2 2016 Results - Earnings Call Transcript
Aug. 7, 2016 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q1 2016 Results - Earnings Call Transcript
May 4, 2016 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q4 2015 Results - Earnings Call Transcript
Feb. 22, 2016 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q4 2015 Results - Earnings Call Webcast
Feb. 22, 2016 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q3 2015 Results - Earnings Call Transcript
Nov. 4, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q3 2015 Results - Earnings Call Webcast
Nov. 4, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q2 2015 Results - Earnings Call Transcript
Aug. 5, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q2 2015 Results - Earnings Call Webcast
Aug. 5, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q1 2015 Results - Earnings Call Webcast
May 6, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q1 2015 Results - Earnings call Transcript
May 6, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q4 2014 Results -- Earnings Call Transcript
Feb. 23, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q4 2014 Results - Earnings Call Webcast
Feb. 23, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q3 2014 Results - Earnings Call Transcript
Nov. 10, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q3 2014 Results - Earnings Call Webcast
Nov. 10, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q2 2014 Results - Earnings Call Transcript
Aug. 19, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q1 2014 Results - Earnings Call Transcript
May 12, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Discusses Q4 2013 Results (Webcast)
March 3, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma CEO Discusses Q4 2013 Results - Earnings Call Transcript
March 3, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Presents at Piper Jaffray 2013 Healthcare Conference (Transcript)
Dec. 3, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Presents at Jeffries 2013 Global Healthcare Conference (Transcript)
Nov. 21, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma at Credit Suisse Healthcare Conference Transcript
Nov. 13, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma's CEO Presents at Credit Suisse Healthcare Conference (Transcript)
Nov. 13, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Discusses Q3 2013 Results - Earnings Call Transcript
Nov. 6, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q3 2013 Earnings Conference Call Transcript
Nov. 6, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma Q2 2013 Earnings Conference Call Transcript
Aug. 8, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma's CEO Discusses Q2 2013 Results - Earnings Call Transcript
Aug. 8, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Management Discusses Q2 2013 Results (Webcast)
Aug. 8, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma at Goldman Sachs Healthcare Conference Transcript
June 11, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma CEO Presents at Goldman Sachs Healthcare Conference (Transcript)
June 11, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma at Jefferies Global Healthcare Conference Transcript
June 6, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma CEO Discuses Q1 2013 Results - Earnings Call Transcript
May 9, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q1 2013 Earnings Conference Call Transcript
May 9, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma at Cowen Health Care Conference Transcript
March 6, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma Q4 2012 Earnings Conference Call Transcript
March 1, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma's CEO Discusses Q4 2012 Results - Earnings Call Transcript
March 1, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma at RBC Capital Markets\' Healthcare Conference Transcript
Feb. 27, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma's CEO Presents at 31st Annual JPMorgan Healthcare Conference (Transcript)
Jan. 10, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma at JPMorgan Global Healthcare Conference Transcript
Jan. 10, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma's CEO Presents at Lazard Capital Markets Healthcare Conference - Transcript
Nov. 13, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Nov. 5, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q3 2012 Earnings Conference Call Transcript
Nov. 5, 2012 | Price: $106.00 | Source: Thomson

PDL BioPharma at UBS Global Life Sciences Conference Transcript
Sept. 19, 2012 | Price: $54.00 | Source: Thomson

PDL BioPharma's Management Presents at UBS Global Life Sciences Conference (Transcript)
Sept. 19, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma at Think Equity Growth Conference Transcript
Sept. 13, 2012 | Price: $54.00 | Source: Thomson

PDL BioPharma at Rodman & Renshaw Global Investment Conference Transcript
Sept. 11, 2012 | Price: $54.00 | Source: Thomson

PDL BioPharma's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Aug. 4, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q2 2012 Earnings Conference Call Transcript
Aug. 2, 2012 | Price: $54.00 | Source: Thomson

PDL BioPharma President Presents at Goldman Sachs Annual Global Healthcare Conference (Transcript)
June 7, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc.(PDLI) Q1 2012 Earnings Call Transcript
May 3, 2012 | Price: Free! | Source: Morningstar

PDL BioPharma's CEO Discusses Q1 2012 Results - Earnings Call Transcript
May 3, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Feb. 23, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Presents at 30th Annual JP Morgan Healthcare Conference (Transcript)
Jan. 12, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Discusses Q3 2011 Results - Earnings Call Transcript
Nov. 9, 2011 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc.(PDLI) Q3 2011 Earnings Call Transcript
Nov. 9, 2011 | Price: Free! | Source: Morningstar

PDL Biopharma's CEO Discusses Q2 2011 Results - Earnings Call Transcript
July 27, 2011 | Price: Free! | Source: Seeking Alpha

PDL Biopharma's CEO Discusses Q1 2011 Results - Earnings Call Transcript
April 27, 2011 | Price: Free! | Source: Seeking Alpha

PDL BioPharma CEO Discusses Q4 2010 Results - Earnings Call Transcript
Feb. 28, 2011 | Price: Free! | Source: Seeking Alpha

PDL BioPharma CEO Discusses Q3 2010 Results – Earnings Call Transcript
Nov. 10, 2010 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q2 2010 Earnings Call Transcript
July 28, 2010 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q1 2010 Earnings Call Transcript
April 29, 2010 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q4 2009 Earnings Call Transcript
March 2, 2010 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q3 2009 Earnings Call Transcript
Oct. 28, 2009 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q2 2009 Earnings Call Transcript
July 30, 2009 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q1 2009 Earnings Call Transcript
May 7, 2009 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q4 2008 Earnings Call Transcript
March 2, 2009 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Inc. Q3 2008 Earnings Call Transcript
Nov. 6, 2008 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q2 2007 Earnings Call Transcript
Aug. 1, 2007 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q1 2007 Earnings Call Transcript
May 2, 2007 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q4 2006 Earnings Call Transcript
Feb. 21, 2007 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q3 2006 Earnings Call Transcript
Nov. 3, 2006 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Inc. Q1 2006 Earnings Conference Call Transcript (PDLI)
May 3, 2006 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q4 2005 Earnings Conference Call Transcript (PDLI)
Feb. 28, 2006 | Price: Free! | Source: Seeking Alpha

Recent filings

PDL: Unaudited Pro Forma Condensed Consolidated Financial Information - Oct. 7, 2020

Tender offer statement by Issuer - Oct. 5, 2020

Pdl Biopharma Completes Spin-Off Of Lensar - Oct. 2, 2020

Major owner of PDL BioPharma just disposed of 8,658,694 shares - Oct. 1, 2020

Major owner of PDL BioPharma just declared owning 8,658,694 shares of PDL BioPharma - Sept. 17, 2020

Tender offer statement by Issuer - Sept. 15, 2020

Regulation FD - Sept. 10, 2020

Pdl Biopharma To Complete Spin-Off Of Lensar, Inc. On October 1, 2020 - Sept. 10, 2020

Pdl Biopharma Completes Divestiture Of The Noden Pharmaceutical Business To Stanley Capital - Sept. 9, 2020

Amendments to Articles of Incorporation or - Sept. 1, 2020

Pdl Biopharma Announces Sale Of Kybella - Aug. 31, 2020

Tender offer statement by Issuer - Aug. 28, 2020

Peter S. Park just provided an update on share ownership of PDL BioPharma - Aug. 28, 2020

Pdl Biopharma Announces Offer To Purchase Convertible Notes Due 2021 And 2024 - Aug. 28, 2020

Peter S. Park just provided an update on share ownership of PDL BioPharma - Aug. 28, 2020

Pdl Biopharma Announces Filing Of A Form 10 Registration Statement With The Securities And Exchange Commission For A Potential Spin-Off Of Lensar To Pdl’S Stockholders - Aug. 26, 2020

PDL BioPharma director just picked up 25,826 shares - Aug. 24, 2020

PDL BioPharma director just picked up 25,826 shares - Aug. 24, 2020

PDL BioPharma director just picked up 25,826 shares - Aug. 24, 2020

PDL BioPharma director just picked up 25,826 shares - Aug. 24, 2020

PDL BioPharma director just picked up 25,826 shares - Aug. 24, 2020

Departure of Directors or Certain - Aug. 20, 2020

Pdl Biopharma Enters Into Settlement Agreement With Wellstat - Aug. 12, 2020

PDL BioPharma Just Filed Its Quarterly Report: 20. Net (Loss) Incom... - Aug. 10, 2020

PDL: (2) Form, Schedule Or Registration Statement No - Aug. 6, 2020

PDL: (2) Form, Schedule Or Registration Statement No - Aug. 6, 2020

Pdl Biopharma Reports 2020 Second Quarter Financial Results - Aug. 6, 2020

Pdl Biopharma Enters Into Agreement For The - July 30, 2020

Departure of Directors or Certain - July 28, 2020

Results of Operations and Financial - July 17, 2020

PDL BioPharma releases salary data. CEO sees compensation rise 168% - July 7, 2020

Preliminary Proxy Soliciting materials - June 30, 2020

Current report, items 8.01 and 9.01 - June 30, 2020

On June - June 23, 2020

Preliminary Proxy Soliciting materials - June 5, 2020

PDL BioPharma, Inc. just provided an update on activist position in PDL BioPharma - May 26, 2020

Major owner of PDL BioPharma just disposed of 13,333,334 shares - May 26, 2020

Pdl Biopharma Completes Distribution Of Evofem Biosciences Common Stock To Pdl Stockholders - May 21, 2020

Pdl Biopharma Declares Distribution Ratio For Dividend Of Evofem Biosciences Common Stock To Pdl Stockholders - May 18, 2020

PDL BioPharma Just Filed Its Quarterly Report: . Net (Loss) Income ... - May 11, 2020

Pdl Biopharma Reports 2020 First Quarter Financial Results - May 7, 2020

Pdl Biopharma Reports 2020 First Quarter Financial Results - May 7, 2020

Other preliminary proxy statements - May 5, 2020

Pdl Biopharma Declares Dividend Of Evofem Biosciences Common Stock To Pdl Stockholders - May 5, 2020

Departure of Directors or Certain - May 4, 2020

PDL: Item 10. Directors, Executive Officers And Corporate Governance Information Regarding Directors - April 29, 2020

PDL BioPharma director just declared 0 ownership of the company. - April 21, 2020

PDL BioPharma director just picked up 7,609 shares - April 21, 2020

VP Finance of PDL BioPharma just picked up 292,208 shares - April 7, 2020

PDL BioPharma's President and CEO just picked up 1,233,766 shares - April 7, 2020

VP Finance of PDL BioPharma just disposed of 82,488 shares - April 7, 2020

PDL BioPharma's President and CEO just disposed of 672,505 shares - April 7, 2020

VP of PDL BioPharma just picked up 194,805 shares - April 7, 2020

VP of PDL BioPharma just picked up 422,078 shares - April 7, 2020

VP of PDL BioPharma just disposed of 3,926 shares - April 7, 2020

Pdl Biopharma Reports 2019 Fourth Quarter And Full Year Financial Results - March 11, 2020

PDL BioPharma Just Filed Its Annual Report: 23. Net (Loss) Incom... - March 11, 2020

Pdl Biopharma Reports 2019 Fourth Quarter And Full Year Financial Results - March 11, 2020

ARNAUD AJDLER just provided an update on activist position in PDL BioPharma - March 10, 2020

Pdl Biopharma Announces Appointment Of Edward A. Imbrogno - March 9, 2020

Pdl Biopharma Enters Into Cooperation Agreement With Engine Capital - Feb. 28, 2020

Pdl Biopharma Enters Into Cooperation Agreement With Engine Capital - Feb. 28, 2020

ARNAUD AJDLER just provided an update on activist position in PDL BioPharma - Feb. 28, 2020

Renaissance Technologies LLC just provided an update on share ownership of PDL BioPharma - Feb. 13, 2020

Dimensional Fund Advisors LP just provided an update on share ownership of PDL BioPharma - Feb. 12, 2020

The Vanguard Group just provided an update on share ownership of PDL BioPharma - Feb. 12, 2020

BlackRock, Inc. just provided an update on share ownership of PDL BioPharma - Feb. 5, 2020

PDL: Item 9.01 Financial Statements And Exhibits - Jan. 15, 2020

Regulation FD - Jan. 15, 2020

VP of PDL BioPharma just picked up 422,078 shares - Jan. 10, 2020

VP Finance of PDL BioPharma just picked up 292,208 shares - Jan. 10, 2020

PDL BioPharma's President and CEO just picked up 1,233,766 shares - Jan. 10, 2020

VP of PDL BioPharma just picked up 194,805 shares - Jan. 10, 2020

Glenn Carlson just provided an update on share ownership of PDL BioPharma - Jan. 9, 2020

Departure of Directors or Certain - Dec. 23, 2019

Pdl Biopharma Announces Upcoming Changes To Its Board Of Directors - Dec. 19, 2019

Pdl Biopharma Board Of Directors Increases Share And Note Repurchase Authorization To $275 Million - Dec. 16, 2019

PDL: Convertible Notes Due 2021 And 2024 - Dec. 13, 2019

Pdl Biopharma Announces Completion Of Strategic Review Process - Dec. 9, 2019

Departure of Directors or Certain - Nov. 19, 2019

Pdl Biopharma Reaffirms Commitment To Shareholder Value Creation - Nov. 14, 2019

Pdl Biopharma Reports 2019 Third Quarter Financial Results - Nov. 6, 2019

PDL BioPharma Just Filed Its Quarterly Report: . Net (Loss) Income ... - Nov. 6, 2019

ARNAUD AJDLER just provided an update on activist position in PDL BioPharma - Oct. 23, 2019

Regulation FD - Oct. 21, 2019

PDL BioPharma, Inc. just provided an update on activist position in PDL BioPharma - Oct. 11, 2019

Regulation FD - Oct. 3, 2019

Entry into a Material Definitive - Sept. 17, 2019

Pdl Biopharma Announces Private Exchange Of Approximately $86.1 Million Of - Sept. 13, 2019

Pdl Biopharma Announces Favorable Decision In Wellstat Diagnostics Litigation - Sept. 12, 2019

Departure of Directors or Certain - Aug. 29, 2019

Departure of Directors or Certain - Aug. 19, 2019

PDL BioPharma, Inc. just provided an update on activist position in PDL BioPharma - Aug. 12, 2019

PDL BioPharma Just Filed Its Quarterly Report: . Net (Loss) Income ... - Aug. 7, 2019

Pdl Biopharma Reports 2019 Second Quarter Financial Results - Aug. 7, 2019

PDL BioPharma director was just granted 126,050 options - July 8, 2019

PDL BioPharma Just Received a Notice of Effectiveness - June 27, 2019

Departure of Directors or Certain - June 25, 2019

PDL BioPharma director just picked up 50,000 shares - June 24, 2019

PDL BioPharma director was just granted 126,050 options - June 24, 2019

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. Pinnacle Summer Investments, Inc. 16,672,546 0.1 Dec. 31, 2015
2. First Trust Portfolios L.P. 10,709,055 N/A Oct. 31, 2015
3. DIMENSIONAL FUND ADVISORS LP 9,603,719 N/A June 30, 2020
4. VANGUARD GROUP INC 9,326,891 N/A June 30, 2019
5. RENAISSANCE TECHNOLOGIES LLC 8,294,249 N/A June 30, 2020
6. DEUTSCHE BANK AG\ 7,975,977 N/A June 30, 2018
7. BlackRock Fund Advisors 6,401,415 N/A Sept. 30, 2016
8. State Street Corp 5,974,200 N/A June 30, 2020
9. State Street Corp 5,974,200 N/A June 30, 2020
10. DEUTSCHE BANK AG\ 5,941,820 N/A Dec. 31, 2017
11. BlackRock Institutional Trust Company, N.A. 5,819,729 N/A Dec. 31, 2016
12. BRANDES INVESTMENT PARTNERS, LP 5,351,132 0.4 June 30, 2020
13. NORTHERN TRUST CORP 4,973,948 N/A March 31, 2018
14. Silver Point Capital L.P. 4,900,000 2.0 June 30, 2020
15. Man Investments (CH) AG 4,500,000 2.6 June 30, 2017
16. MORGAN STANLEY 3,492,068 N/A Dec. 31, 2016
17. WELLS FARGO & COMPANY/MN 3,398,399 N/A Sept. 30, 2018
18. State Street Corp 3,156,957 N/A March 31, 2020
19. Citadel Advisors LLC 3,001,136 N/A Dec. 31, 2019
20. Pinnacle Holdings, LLC 2,985,000 1.6 June 30, 2020
21. Connor, Clark & Lunn Investment Management Ltd. 2,970,976 0.1 June 30, 2020
22. Engine Capital Management, LLC 2,676,850 5.2 June 30, 2020
23. Russell Frank Co/ 2,511,507 N/A Sept. 30, 2015
24. SCHWAB CHARLES INVESTMENT MANAGEMENT INC 2,322,843 N/A June 30, 2020
25. Sage Capital Management, LLC 2,044,000 N/A Sept. 30, 2015
26. BNP PARIBAS ARBITRAGE, SA 2,031,884 N/A June 30, 2019
27. D. E. Shaw & Co., Inc. 1,833,312 N/A June 30, 2020
28. GEODE CAPITAL MANAGEMENT, LLC 1,782,834 N/A June 30, 2020
29. GEODE CAPITAL MANAGEMENT, LLC 1,714,587 N/A March 31, 2020
30. Ancora Advisors, LLC 1,693,216 0.1 June 30, 2020
 


Feedback